Epoprostenol Interactions
There are 299 drugs known to interact with epoprostenol, along with 2 disease interactions. Of the total drug interactions, 39 are major, 254 are moderate, and 6 are minor.
- View all 299 medications that may interact with epoprostenol
- View epoprostenol disease interactions (2)
Most frequently checked interactions
View interaction reports for epoprostenol and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Advair Diskus (fluticasone / salmeterol)
- Amaryl (glimepiride)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aralast (alpha 1-proteinase inhibitor)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Breo Ellipta (fluticasone / vilanterol)
- Bumex (bumetanide)
- Cayston (aztreonam)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Combivent Respimat (albuterol / ipratropium)
- Copper (copper gluconate)
- Coreg (carvedilol)
- Cytoxan (cyclophosphamide)
- Desogen (desogestrel / ethinyl estradiol)
- Dextrose (glucose)
- Dulera (formoterol / mometasone)
- Ethyl Alcohol (ethanol)
- L-Arginine (arginine)
- Lasix (furosemide)
- Paracetamol (acetaminophen)
- Saxenda (liraglutide)
- Sotalol Hydrochloride AF (sotalol)
- Tradjenta (linagliptin)
- Tramadol Hydrochloride ER (tramadol)
- Trulicity (dulaglutide)
- Vitamin D3 (cholecalciferol)
Epoprostenol disease interactions
There are 2 disease interactions with epoprostenol which include:
Report options
QR code containing a link to this page
More about epoprostenol
- epoprostenol consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: agents for pulmonary hypertension
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.